SCHEMBL23979778

SCHEMBL23979778

CCN(CC)CCOC(I)I

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
CYP2D6 P10635 3/20 0.34
CYP1A2 P05177 2/20 0.34
LMNA P02545 1/20 0.34
KDM4E B2RXH2 2/20 0.33
TSHR P16473 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
EBP Q15125 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
LTA4H P09960 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32
BIRC5 O15392 1/20 0.31
MAPT P10636 1/20 0.31
CHRNA7 P36544 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23791204 0.83 MEN1 (0.39) KMT2AMEN1POLBCYP2D6CYP1A2
SCHEMBL14920988 0.77 MEN1 (0.41) KMT2AMEN1POLBCYP2D6CYP1A2
SCHEMBL5002480 0.77 MEN1 (0.41) KMT2AMEN1POLBCYP2D6CYP1A2
SCHEMBL7079430 0.75 MEN1 (0.40) KMT2AMEN1POLBCYP2D6CYP1A2
SCHEMBL24578070 0.74
SCHEMBL25492652 0.73 MEN1 (0.39) KMT2AMEN1POLBCYP2D6CYP1A2
SCHEMBL12398415 0.73 MEN1 (0.39) KMT2AMEN1POLBCYP2D6CYP1A2
SCHEMBL749808 0.73 MEN1 (0.39) KMT2AMEN1POLBCYP2D6CYP1A2
SCHEMBL7751447 0.71 TSHR (0.40) KMT2AMEN1POLBCYP2D6CYP1A2
SCHEMBL28422042 0.71 MEN1 (0.38) KMT2AMEN1POLBCYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022135470-A1 PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUND AS KRAS INHIBITOR 上海科州药物研发有限公司 2022-06-30 WO disclosed
WO-2021219072-A1 PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUND AS KRAS INHIBITOR 上海科州药物研发有限公司 (CN) 2021-11-04 WO disclosed